2:09 PM
 | 
Dec 01, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Codiak raises $76.5M in series C

Exosome therapeutics company Codiak BioSciences Inc. (Cambridge, Mass.) raised $76.5 million in an untranched series C round. Existing investors Alaska Permanent Fund, Alexandria Venture Investments, Arch Venture Partners, Fidelity and Flagship Pioneering were joined by new investors Casdin Capital, EcoR1 Capital, Qatar Investment Authority,...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >